IL3
Interleukin-3
Also known as: IL-3, IL3_HUMAN, MCGF, MGC79398, MGC79399, MULTI-CSF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08700
- Gene
- IL3
- Ensembl
- ENSG00000164399
- Chromosome
- 5
- Canonical length
- 152 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a potent growth promoting cytokine. This cytokine is capable of supporting the proliferation of a broad range of hematopoietic cell types. It is involved in a variety of cell activities such as cell growth, differentiation and apoptosis. This cytokine has been shown to also possess neurotrophic activity, and it may be associated with neurologic disorders. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
152 residues, UniProt reviewed canonical sequence.
>P08700|IL3
1 MSRLPVLLLL QLLVRPGLQA PMTQTTPLKT SWVNCSNMID EIITHLKQPP LPLLDFNNLN
61 GEDQDILMEN NLRRPNLEAF NRAVKSLQNA SAIESILKNL LPCLPLATAA PTRHPIHIKD
121 GDWNEFRRKL TFYLKTLENA QAQQTTLSLA IFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 0.2 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 0.2 nTPM
- epididymis: 0.1 nTPM
- retina: 0.1 nTPM
- testis: 0.1 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
Single-cell type
- innate lymphoid cells: 0.7 nCPM
- late primary spermatocytes: 0.4 nCPM
- mast cells: 0.2 nCPM
- t-cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 1.2 nTPM
- hypothalamus: 1.1 nTPM
- white matter: 1.1 nTPM
- hippocampal formation: 1 nTPM
- medulla oblongata: 1 nTPM
- amygdala: 0.9 nTPM
ReferencesPubMed · IEDB
Publications for IL3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
2004 · Ann Rheum Dis · RCR 0.2 · 8 citations - Binding sites of interleukin-3-mimetic monoclonal autoantibodies derived from a MRL/lpr mouse.
1990 · Autoimmunity · RCR 0 · 1 citations - Synovial Fluid Autoantibodies and Cytokines in Rheumatoid Arthritis Potential Biomarkers and Insight into Disease Pathogenesis.
2026 · Arch Med Res · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.93
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.23
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via STAT
- cell-cell signaling
- embryonic hemopoiesis
- immune response
- interleukin-3-mediated signaling pathway
- nervous system development
- positive regulation of cell population proliferation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Four-helical cytokine-like, core
- Interleukin-3
- Interleukin-3
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL3 as an antibody target. Whether an autoantibody or antibody against IL3 could matter depends on whether native IL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL3 is annotated as secreted, so native IL3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...